Evogene Reports Q1 2026 Results as AgPlenus Herbicide and Fungicide Programs Advance
Sepehr Achard
Evogene Ltd. (NASDAQ: EVGN) reported a Q1 2026 net loss of approximately $5.9 million, compared to $3.0 million in Q1 2025, driven by lower revenues and higher net financing expenses. The post Evogene Reports Q1 2026 Results as AgPlenus Herbicide and Fungicide Programs Advance appeared first on iGrow News .